PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Ghayas C. Issa

The University of Texas MD Anderson Cancer Center

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 13, 2026 · JOURNAL ARTICLE

Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia

Cancer

Retrospective cohort analysis identifying prognostic factors and comparing outcomes across therapies in NPM1-mutated AML, with clear survival endpoints but limited by single-center design and observational methodology.

PromisingAcute Myeloid Leukemia Research Koji Sasaki Georgina El Hajjar

Reported

Sample size396

High-intensity chemotherapy media…84.7 months

High-intensity chemotherapy 5-yea…53%

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support